YES!Delft and EIT Health cooperate in Bootcamp for start-ups
After months of preparation EIT Health and YES!Delft have selected 11 MedTech start-ups out of more than 80 applications for the EIT Health Bootcamp LaunchLab.
This autumn, teams from all over Europe will participate in the EIT Health Bootcamp programme to validate incredibly promising health and medtech ideas. From self-ownership over genetic DNA to real time adaptation of oxygen flow to cleaning hospital robots.
Starting 5 September, the teams will travel from Delft, Netherlands, to Germany, Belgium and Sweden, to validate their tech ideas and find their product/market fit.
The program is a unique two-month pressure cooker that allows aspiring entrepreneurs from all over Europe to discover the business potential of their health-tech ideas. It helps participants to explore and validate their ideas, market potential and business model – and to launch in markets all over Europe.
EIT Health Bootcamp LaunchLab is a partnership between YES!Delft and EIT Health partners. It combines the extensive knowledge and network of EIT Health partners with YES!Delft's startup expertise.
The following are the teams selected, with their own descriptions of what they do:
Clemedi (Germany): Fights antibiotic resistance by giving the doctors all the information needed for the right treatment early on, therefore reducing hospital costs and improving patient care.
Ergotrics (Belgium): develops and manufactures inflatables using compressed air which allow for the optimal positioning or moving of patients.
FreeMyGenome (Netherlands): Our mission is to provide self-ownership over genetic DNA and control over who gets access to it, in the hands of every human on the planet. Every person on earth should own their DNA in a reliable and highly secure digital safe that also enables the person to grant controlled access of his/her genetic DNA to people of their choice and being able to choose to share data with renowned research institutes around the world and accelerate new scientific breakthroughs. To be in control. To have choice.
humanITcare (Spain): We create innovative technological solu:ons based on research and science to improve quality of life of people.
HydrUStent (Portugal): Our product is a degradable stent that will revolutionise the market. Providing lower treatment cost, avoiding second surgery for stent removal, while reducing the risk of infection and eliminates the cases of “forgotten” stents. It’s for patients who need temporary urological stents, who need to have a second surgery for stent removal.
iBreve (Spain): The wearable that fights stress by analyzing breathing patterns in real time. iBreve is founded by two former Google employees aiming to create a world free of stress related diseases.
Inossia AB (Sweden): We provide a bone cement designed for osteoporotic bone. It gives the patient better treatment, less risk for new fractures and better quality of life after a fragility fracture. We aim to collaborate with bone cement manufacturers for fast time to market.
Knowing (Germany): Science generates data but knowledge grows slowly. We store, integrate and connect biomedical data to make drug development and therapies truly individual.
Oxypoint (Belgium): Smart electronic flowmeter that improves oxygen therapy by real time adaptation of oxygen flow through analysis of oxygen data (saturation, breaths per minute), communicates with other devices to have an benificial effect on the rehabilitation process of the patient and delivers oxygen much more comfortably whilst reducing oxygen consumption and spillage.
S.Bot (Germany): We are creating a robot that can wash and disinfect or sterilize hospital floors regardless of what hour of day or night or number of cleanings are needed. Our product will be easy to use and maintain, and drastically reduce infections rate, treatment and personnel costs. More than that, patients feel safe and are reassured that their safety is your top priority.
STIL (Netherlands): People with Essential Tremor have involuntary vibrations in the arms, making them unable to perform even the simplest tasks in life, such as eating and drinking. Current treatments have severe side-effects, causing patients to reject it and live with the consequences. STIL technology is capable of mechanically suppressing tremor and will provide a stable future for 30 million people worldwide.
You can learn more about the LaunchLab programme here.
Catch up with the latest news from the EIT Community in the Newsroom.